Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
But all three drugs have new competitors. Meanwhile, BioMarin’s gene therapy Roctavian is approved by the FDA for the treatment of hemophilia A. percent increase since 2021, predominantly due to Botox sales for therapeutic uses. Botox was first approved by the FDA in 1989 for blepharospasms and strabismus in adults.
98 
Let's personalize your content